June 1, 2009
View Archives Issues
In the past half century, technology, environmental awareness, and modern science have surged. Yet, as in all generations, a significant number of consumers, perhaps intent upon getting back to simpler times, are choosing "healthful" therapies not fully accepted by the mainstream.
NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.